Teladoc Health Reports Q2 2025 Revenue Decline of 2% YoY, Net Loss of $32.7 Million, EPS at $0.19

Reuters
2025/07/30
Teladoc Health Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Decline of 2% YoY, Net Loss of $32.7 Million, EPS at $0.19

Teladoc Health Inc., a leader in virtual care, reported its financial results for the second quarter of 2025, showing a revenue of $631.9 million, marking a 2% decline compared to the same period in 2024. The company posted a net loss of $32.7 million for the quarter, translating to a loss of $0.19 per share. Adjusted EBITDA for the second quarter was $69.3 million, down 23% from the previous year. In terms of segment performance, the Integrated Care segment reported revenue of $391.5 million, reflecting a 4% increase year-over-year, with an adjusted EBITDA margin of 14.7%. Conversely, the BetterHelp segment's revenue decreased by 9% year-over-year to $240.4 million, with an adjusted EBITDA margin of 4.9%. Teladoc Health also announced that they used $550.6 million in cash to retire convertible senior notes due in the second quarter of 2025. Additionally, on July 17, 2025, the company entered into a credit agreement for a $300.0 million senior secured revolving credit facility to enhance financial and operational flexibility. For the full year of 2025, Teladoc Health expects revenue between $2.501 billion and $2.548 billion, with an adjusted EBITDA range of $263 million to $294 million. The net loss per share is projected to be between $1.35 and $1.00. The company's outlook anticipates revenue growth for its Integrated Care segment at 1.75% to 3.25%, while the BetterHelp segment is expected to see a revenue decline of 9.20% to 6.80%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teladoc Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9502563-en) on July 29, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10